Richard Horgan has waited for this moment for more than three years.
Last month, the Food and Drug Administration granted permission for his younger brother Terry, 27, who lives with muscular dystrophy, to receive a first-of-its-kind gene therapy that was tailor-made for his genetic mutation.
When the infusion of the drug happens at UMass Chan Medical School, it will be an emotional moment for Terry and Richard, the driving force behind the experimental drug.
Create a display name to comment
This name will appear with your comment
